Regulated Step in Cholesterol Feedback Localized to Budding of SCAP from ER Membranes  by Nohturfft, Axel et al.
Cell, Vol. 102, 315±323, August 4, 2000, Copyright ª 2000 by Cell Press
Regulated Step in Cholesterol Feedback Localized
to Budding of SCAP from ER Membranes
The first cleavage is catalyzed by a membrane-bound
serine protease, designated Site-1 protease (S1P), that
clips SREBPs at a leucine±serine bond within the luminal
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loop that links the two transmembrane domains (DuncanDepartment of Molecular Genetics
et al., 1997). This cleavage generates the substrate forUniversity of Texas
a second enzyme, a membrane-bound zinc metallopro-Southwestern Medical Center
tease, designated Site-2 protease (S2P), that cleavesDallas, Texas 75390
the NH2-terminal fragment of each SREBP at a point
that is three amino acids into the first transmembrane
domain (Rawson et al., 1997; Duncan et al., 1998). The
released NH2-terminal fragment migrates to the nucleus
Summary where it activates transcription of the LDL receptor gene
and more than 20 genes involved in lipid biosynthesis
SREBPs exit the ER in a complex with SCAP. Together, (Brown and Goldstein, 1997; Edwards and Ericsson,
they move to the Golgi where SREBP is cleaved, re- 1999). When cholesterol levels rise in cells, SREBPs
leasing a fragment that activates genes encoding lipid are no longer cleaved by S1P. As a result, cholesterol
biosynthetic enzymes. Sterols block ER exit, pre- synthesis and uptake of LDL decrease, thereby main-
taining cholesterol homeostasis in a classic feedbackventing cleavage, decreasing transcription, and achiev-
fashion (Brown and Goldstein, 1997).ing feedback control of lipid synthesis. Here, we report
Cleavage of SREBPs by S1P requires the action ofan in vitro system to measure incorporation of SCAP
SREBP Cleavage-Activating Protein (SCAP), a polytopicinto ER vesicles. When membranes were isolated from
membrane protein of 1276 amino acids (Hua et al.,sterol-depleted cells, SCAP entered vesicles in a reac-
1996a). SCAP is divided broadly into two domains (Noh-tion requiring nucleoside triphosphates and cytosol.
turfft et al., 1998a). The NH2-terminal 730 amino acidsSCAP budding was diminished in membranes from
are thought to form eight membrane-spanning seg-sterol-treated cells. Kinetics of induction of budding
ments with three N-linked oligosaccharide chains at-in vitro matched kinetics of ER exit in living cells ex-
tached to the luminal loops. The COOH-terminal 546pressing GFP-SCAP. These data localize the sterol-
amino acids project into the cytosol and contain fiveregulated step to budding of SCAP from ER and pro-
copies of a protein/protein interaction motif called the
vide a system for biochemical dissection. WD repeat. The WD repeat domain of SCAP binds to the
COOH-terminal regulatory domain of SREBP, forming a
Introduction complex that is required for SREBP cleavage by S1P
(Sakai et al., 1997, 1998). Complex formation is also
Cholesterol homeostasis in mammalian cells is con- essential to stabilize the SREBP precursor. In mutant
trolled by a feedback regulatory system that senses cells that lack SCAP, the levels of all SREBP precursors
the cholesterol content of membranes and appropriately are reduced, apparently as a result of premature degra-
modulates the transcription of genes required for cho- dation, and there is also no cleavage by S1P (Rawson
lesterol supply. The coordinate expression of these et al., 1999).
genes is orchestrated by a family of membrane-bound A clue to the role of SCAP emerged from the observa-
transcription factors called Sterol Regulatory Element tion that the uncleaved precursor forms of SREBPs are
Binding Proteins (SREBPs) (Brown and Goldstein, 1997, found in the ER (Wang et al., 1994; Duncan et al., 1997),
1999). whereas the active form of S1P is located in a post-ER
Newly synthesized SREBPs are embedded in mem- compartment (DeBose-Boyd et al., 1999; Espenshade
branes of the ER and nuclear envelope in a hairpin orien- et al., 1999). Cleavage of SREBPs thus requires that the
tation. SREBPs are comprised of three domains: (1) an SREBPs be transported from the ER to the post-ER
NH2-terminal domain of z480 amino acids that faces compartment, most likely the Golgi. This conclusion is
the cytosol and functions as a transcription factor of supported by experiments in which S1P was artificially
the basic helix-loop-helix-leucine zipper family; (2) a induced to relocate from the Golgi to the ER. Under
membrane-anchoring domain of z80 amino acids con- those conditions, the SREBPs were cleaved by S1P in
sisting of two membrane-spanning sequences that are a reaction that no longer required SCAP and was no
separated by a hydrophilic loop of z30 amino acids that longer inhibited by sterols (DeBose-Boyd et al., 1999).
projects into the lumen; and (3) a regulatory domain of Biochemical and genetic evidence has led to a model
z590 amino acids that extends into the cytosol (Brown in which SCAP carries SREBPs from the ER to the Golgi
and Goldstein, 1997). and cholesterol blocks this transport. This model is sup-
The activities of all three SREBP isoforms (SREBP- ported by analysis of the N-linked oligosaccharides of
1a, -1c, and -2) are regulated by the cell's sterol content. SCAP. In cells replete with cholesterol, the N-linked oli-
In sterol-depleted cells, two sequential cleavages re- gosaccharide chains on SCAP are sensitive to hydroly-
lease the NH2-terminal transcription factor domains of sis by endoglycosidase H (endo H), indicating that SCAP
SREBPs from membranes (Brown and Goldstein, 1999). is located in the ER. Upon sterol depletion, the oligosac-
charide chains on SCAP become resistant to endo H as a
consequence of modification by Golgi-specific enzymes* To whom correspondence should be addressed (e-mail: jgolds@
mednet.swmed.edu [J. L. G.], mbrow1@mednet.swmed.edu [M. S. B.]). (Nohturfft et al., 1998b, 1999). Cholesterol modulates
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stably transfected with the GFP-SCAP cDNA (lanes 3
and 4). GFP-SCAP raised the level of the SREBP-2 pre-
cursor in membranes and permitted the generation of
the cleaved nuclear fragment in a sterol-regulated
fashion.
Figure 2 shows an experiment in which we used confo-
cal microscopy to examine the subcellular localization
of GFP-SCAP in the stably transfected SRD-13A cells.
When the GFP-SCAP cells were cultured in medium
containing fetal calf serum (FCS) as a source of sterols,
GFP-SCAP displayed a diffuse, reticular pattern cor-
responding to the ER (panel A). Antibodies to Golgi
a-mannosidase II (panel B) stained a structure that
Figure 1. GFP-SCAP Restores Sterol-Regulated Cleavage of showed little overlap with GFP-SCAP under these condi-
SREBP-2 in SCAP-Deficient Hamster Cells
tions (panel C). To deplete the cells of sterols, we incu-
On day 0, SCAP-deficient SRD-13A cells (lanes 1 and 2) and SRD- bated the cells for 5 hr in medium containing 1% hydro-
13A cells stably transfected with pGFP-SCAP (CHO/pGFP-SCAP
xypropyl-b-cyclodextrin (HPCD), an agent that is knowncells) (lanes 3 and 4) were set up at a density of 4 3 105 cells per
to remove sterols from intact cells (Kilsdonk et al., 1995).60 mm dish in medium A supplemented with 5% FCS. On day 1,
After this treatment, GFP-SCAP showed strong jux-cells were switched to medium A supplemented with 5% newborn
tanuclear staining in addition to the reticular ER pat-calf lipoprotein-deficient serum and 1% (w/v) HPCD in the absence or
tern (panel D). Colocalization of GFP-SCAP with Golgipresence of sterols (10 mg/ml 25-HC plus 10 mg/ml cholesterol in 0.2%
(v/v) ethanol). After incubation for 2 hr at 378C, cells were harvested, and a-mannosidase II (panel E) confirmed the localization of
membrane and nuclear extract fractions were prepared as described GFP-SCAP in or near the Golgi (panel F). In contrast,
(DeBose-Boyd et al., 1999). Aliquots of membranes (9 mg and 2 mg when cells were incubated with HPCD in the presence of
for SREBP-2 and SCAP blots, respectively) and nuclear extracts sterols, GFP-SCAP remained localized to the ER (panels
(15 mg) were subjected to 8% SDS-PAGE and immunoblotted with G±I). The signal for GFP-SCAP was specific inasmuch
antibodies to SREBP-2 (IgG-7D4) or SCAP (IgG-R139). P and N
as nontransfected SRD-13A cells showed no detectabledenote the precursor and nuclear forms of SREBP-2, respectively.
fluorescence under similar conditions (data not shown).
These data indicate that GFP-SCAP moves to the Golgi
region in sterol-depleted, but not sterol-overloaded
this ER-to-Golgi transport of SCAP by interacting, di- cells.
rectly or indirectly, with an z170 amino acid segment To study the movement of GFP-SCAP from the ER to
within the polytopic membrane attachment domain of the Golgi in more detail, we used time-lapse confocal
SCAP that has been termed the sterol-sensing domain. microscopy of living cells to follow the movement of
Domains with similar sequences have been identified in GFP-SCAP upon removal of sterols (Figure 3). To begin
several membrane proteins whose actions are related the experiment, cells were cultured in FCS and then
to cholesterol (Brown and Goldstein, 1999). switched to medium containing HPCD in the absence
In the current study, we use a green fluorescent pro- of sterols. At t 5 0 min, GFP-SCAP was localized to the
tein (GFP)-SCAP fusion protein to visualize the transport ER in a diffuse, reticular pattern. As early as 15 min after
of SCAP from the ER to the Golgi in sterol-deprived addition of HPCD, GFP-SCAP was seen in vesicular
cells. We then establish an in vitro system to measure structures that originated from peripheral sites in the
the incorporation of SCAP into ER-derived membrane ER and appeared to migrate toward the Golgi. These
vesicles. Using this assay, we show that sterol depriva- structures resembled the transport intermediates ob-
tion of intact cells renders the ER membrane competent served during the movement of GFP-tagged vesicular
to discharge SCAP into budding vesicles in vitro and that stomatitis virus glycoprotein (VSVG) from the ER to Golgi
the time course for the acquisition of this competence in living cells (Presley et al., 1997). As shown in Figure
matches the time course for the exit of GFP-SCAP from 3, by 30 min we observed obvious accumulation of GFP-
the ER in vivo. SCAP in the Golgi region. In the time-lapse micrographs,
we observed that transport intermediates continued to
Results form, and GFP-SCAP became increasingly concen-
trated in the Golgi region over the 2.5 hr. The time-
Visualizing ER-to-Golgi Transport of SCAP lapse movie can be viewed at http://www.cell.com/cgi/
in Living Cells content/full/102/3/315/DC1.
To study the transport of SCAP from ER to Golgi in living
cells, we constructed a chimeric cDNA encoding the Reconstituting ER Export of SCAP In Vitro
green fluorescent protein (GFP) attached to the NH2 ter- Transport of proteins from the ER to the Golgi is initiated
minus of hamster SCAP, thereby orienting the GFP do- by the incorporation of cargo proteins into transport
main toward the cytoplasmic face of the membrane. The vesicles that bud from the ER and subsequently fuse
biological activity of this GFP-SCAP fusion protein was with cis elements of the Golgi (Palade, 1975). In impor-
assessed by stably transfecting the GFP-SCAP cDNA tant experiments, Rexach et al. (1991) and Rowe et al.
into mutant CHO cells (designated SRD-13A) that lack (1996) established systems in which the formation of
SCAP activity. SRD-13A cells express no detectable ER-derived transport vesicles can be reconstituted in
SCAP mRNA or protein, which leads to markedly re- vitro by incubating microsomes in the presence of nucle-
duced levels of the precursor as well as the nuclear oside triphosphates (ATP/GTP) and cytosol. Vesicles
forms of SREBP (Rawson et al., 1999). Figure 1 shows formed during this reaction are found in the supernatant
an immunoblot analysis of endogenous SREBP-2 and after centrifugation at 16,000 3 g, whereas the donor
its proteolytic processing in nontransfected SRD-13A membranes are found in the pellet (Rexach and Schek-
man, 1991; Rowe et al., 1996). We used the methodscells (lanes 1 and 2) and in SRD-13A cells that had been
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Figure 2. Visualization of Sterol-Regulated
ER-to-Golgi Transport of GFP-SCAP in Ham-
ster Cells
Stably transfected CHO/pGFP-SCAP cells
were set up as described in Experimental
Procedures in medium A containing 5% FCS.
On day 2, cells were switched to medium A
supplemented with 5% lipoprotein-deficient
serum and 1% HPCD in the absence or pres-
ence of sterols (10 mg/ml 25-HC and 10 mg/
ml cholesterol in 0.2% ethanol). After 5 hr at
378C, cells were fixed and stained with anti-
body as previously described (Sakai et al.,
1997) except that 0.5% (v/v) Triton X-100 was
used for cell permeabilization. Antiserum
against Golgi a-mannosidase II (1:1000 dilu-
tion) was visualized with 15 mg/ml goat anti-
rabbit IgG conjugated to Alexa 594 (Molecular
Probes). Cells were imaged for GFP-SCAP (A,
D, and G) or a-mannosidase II (B, E, and H)
using a confocal microscope (Sakai et al.,
1997). Panels (C), (F), and (I) are merged im-
ages of GFP-SCAP and Golgi a-mannosidase
II. Bar, 10 mm.
established by these laboratories to study the incorpora- remained in the donor membranes (lanes 9±11). For
comparison, we also blotted with an antibody againsttion of SCAP into ER-derived vesicles in vitro.
Figure 4 shows the basic features of the in vitro vesi- p58, a type I membrane protein that cycles between ER
and post-ER compartments (Klumperman et al., 1998)cle-formation assay. CHO-K1 cells were grown in the
presence of lipoprotein-deficient serum and HPCD to and has been previously used as a marker to study ER
export in vitro (Rowe et al., 1996). As shown in the sec-deplete the cells of cholesterol. Microsomes were iso-
lated from these cells by centrifugation and incubated ond panel of Figure 4, p58 was released into the vesicle
fraction. This reaction also required ATP/GTP, cytosol,under conditions that permit budding of vesicles. The
resulting vesicle and membrane fractions were sepa- and temperature (compare lanes 1±3 with lane 8). The
efficiency of SCAP budding in Figure 4, as determinedrated by centrifugation and analyzed for the presence
of SCAP and other proteins by SDS-PAGE and immu- by scanning the immunoblot and quantifying it by densi-
tometry, was 27% at 15 min as compared to 20% fornoblotting. Incubation of microsomes in the presence
of cytosol and nucleoside triphosphates (ATP, GTP, and p58. In the seven other experiments described below,
the efficiency of SCAP budding ranged from 11% toan ATP-regenerating system) at 378C led to the time-
dependent appearance of SCAP in the vesicle fraction 63% with a mean of 27%.
To exclude the possibility that the vesicle fraction(top panel of Figure 4, lanes 4±8). When ATP/GTP or
cytosol was omitted from the reaction mixture or when was created by nonspecific fragmentation of the donor
membranes, the fractions were analyzed with antibodiesthe reaction was incubated on ice, no SCAP was found
in the vesicle fraction (lanes 1±3), and all of the SCAP against the ER-resident proteins grp94, grp78 (BiP), and
Figure 3. Visualization of Transport of GFP-
SCAP from ER-to-Golgi in Living Hamster
Cells
On day 0, stably transfected CHO/pGFP-
SCAP cells were set up in medium A supple-
mented with 5% FCS. On day 2 at t 5 0 hr,
cells were switched to medium A supple-
mented with 5% lipoprotein-deficient serum
and 1% HPCD in the absence of sterols. Cells
were maintained at 378C in 5% CO2, and im-
ages were collected every 2.5 min for 2.5 hr
using a confocal microscope with an open
pinhole. Bar, 10 mm. A QuickTime movie se-





Figure 4. SCAP from Cholesterol-Depleted Hamster Cells Is Incor-
porated into Vesicles In Vitro
On day 0, CHO-K1 cells were set up at 8 3 105 cells per 10 cm dish
in medium A containing 5% FCS. On day 2, cells were switched to
medium A containing 5% lipoprotein-deficient serum and 1% HPCD,
incubated for 2 hr at 378C, and harvested. Microsomes were pre- Figure 5. Induction of SCAP Budding In Vitro and SREBP Cleavage
pared and incubated in vitro at 378C for the indicated time in the In Vivo upon Treatment of Hamster Cells with HPCD
presence of cytosol, ATP, GTP, and an ATP-regenerating system On day 0, CHO-K1 cells were set up as described in Figure 4. On
as described in Experimental Procedures. The mixtures were centri- day 2, cells were refed with medium A containing 5% lipoprotein-
fuged to separate vesicle and membrane fractions that were sub- deficient serum, 10 mg/ml cholesterol, 1 mg/ml 25-HC, 0.5% ethanol,
jected to SDS-PAGE and immunoblotted with IgG-R139 (anti-SCAP), and incubated for 3 hr at 378C. The cells were then deprived of
anti-p58, anti-KDEL (grp94 and grp78), and anti-ribophorin I as indi- sterols by switching to medium A containing 5% lipoprotein-defi-
cated. cient serum, 1% HPCD, and 0.5% ethanol for the indicated time.
Cells were fed with the HPCD-containing medium in a staggered
fashion such that they were all harvested at the same time at 120ribophorin I. All three proteins remained confined to the
min. All cells received 25 mg/ml ALLN added in 0.1% DMSO duringdonor membranes (lanes 9±16), and none were visual-
the last 120 min.
ized in the vesicle fraction (lanes 1±8). Taken together, (A) Microsomes were prepared and used in an in vitro vesicle-forma-
the results of Figure 4 show that the incorporation of tion assay as described in Figure 4. The resulting vesicle and mem-
SCAP into vesicles in vitro constitutes a specific sorting brane fractions were subjected to SDS-PAGE and immunoblotted
event that is dependent on nucleoside triphosphates, with IgG-R139 (anti-SCAP).
(B) Total cell extracts were prepared by lysing washed cell mono-cytosol, and temperature.
layers with 200 ml of Buffer C, after which the lysates from duplicate
dishes were pooled and sheared through a 25-gauge needle. Ali-Sterol Regulation of SCAP Budding
quots (100 mg protein) were subjected to 8% SDS-PAGE and immu-The next set of experiments was designed to determine
noblotted with IgG-2A4 (top) and IgG-7D4 (bottom), respectively. Pwhether incorporation of SCAP into vesicles is sup- and N denote the precursor and nuclear mature forms of SREBPs,
pressed when cells have been loaded with sterols. In respectively.
Figure 5A, CHO-K1 cells were initially grown in the pres-
ence of cholesterol and 25-hydroxycholesterol (25-HC),
which causes SCAP to be retained in the ER (see Figures medium led to the appearance of the nuclear mature
form of both SREBPs after 60 min (lane 4). After 1202 and 3) (Nohturfft et al., 1998b, 1999). Subsequently,
cells were switched for increasing periods of time to min, the precursor forms of SREBP-1 and SREBP-2 had
disappeared, and only the nuclear form was seen (lane 5).medium containing HPCD. Microsomes from these cells
were then subjected to an in vitro vesicle-formation Figure 6A shows an experiment in which CHO-K1 cells
were first depleted of sterols and then switched to ste-assay. When cells had been continually grown in the
presence of sterols, very little SCAP was found in the rol-containing medium for increasing periods of time.
Microsomes from these cells were then used in a vesiclevesicle fraction (Figure 5A, lane 1), and most of the pro-
tein remained in the membrane fraction. The amount of budding assay. In samples from cells grown without
sterols, SCAP was found in the vesicle fraction (lane 4),SCAP released into vesicles increased significantly after
the cells had been incubated in sterol-depleting medium and this effect was dependent on nucleoside triphos-
phates, cytosol, and temperature (lanes 1±3). When thefor only 15 min, and it reached a maximum after 1 hr of
such preincubation (lanes 2±5). Release of SCAP into cells were preincubated with sterols for as little as 0.5
hr, there was a detectable decrease in SCAP buddingthe vesicle fraction did not occur when ATP and GTP
were omitted from the reaction (lane 6). and inhibition was virtually complete after a 2 hr incuba-
tion (lanes 5±8).To compare the induction of SCAP budding with the
kinetics of SREBP cleavage, total cell extracts from the To address the specificity of the sterol-mediated inhi-
bition of SCAP budding, we analyzed the effect of sterolsame cells used in Figure 5A were immunoblotted with
antibodies against SREBP-1 and SREBP-2 (Figure 5B). preincubation on the budding of other proteins that are
known to enter ER-derived transport vesicles. The mostShifting cells from sterol-containing to sterol-depleting
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shifting to 328C, the protein refolds, and it is released
from the ER and transported to the Golgi and then to
the plasma membrane (Beckers et al., 1987; Bergmann,
1989). We generated a CHO-K1 cell line stably express-
ing a fusion protein consisting of VSVG/tsO45 with a
COOH-terminal T7 epitope tag (VSVG-T7). In control ex-
periments, we verified that the N-linked oligosaccha-
rides of VSVG-T7 remained in an endo H±sensitive con-
figuration when cells were grown at 408C, indicating that
the protein was retained in the ER. Upon temperature
shift from 408C to 328C, the protein became endo H
resistant and ran more slowly on SDS-PAGE, owing to
sialylation in the Golgi (Bergmann, 1989).
In Figure 6B, cells were cultured with different concen-
trations of 25-HC at 408C. Membranes were isolated and
incubated at 328C to permit budding of VSVG-T7 in vitro.
Vesicles and membrane fractions were blotted with anti-
bodies against SCAP and VSVG-T7 as well as p58 and
ribophorin I. As expected, increasing concentrations of
25-HC in the culture medium caused SCAP to be ex-
cluded from budding vesicles (lanes 3±6). In contrast,
budding of both VSVG-T7 and p58 was unaffected by 25-
HC. To demonstrate that the VSVG-T7 at 408C resided in
ER membranes, we incubated some of the culture
dishes at 328C. Under these conditions some of the
VSVG-T7 moved to the Golgi where it was modified by
Golgi-resident sialyltransferases and hence the protein
migrated more slowly than the protein isolated from cellsFigure 6. Loss of SCAP Budding in Membranes from Sterol-Treated
grown at 408C (lane 13). As a negative control, we blottedHamster Cells
with an antibody against the ER-resident protein ribo-(A) On day 0, CHO-K1 cells were set up as described in Figure 4.
phorin I. None of this protein was seen in the vesicleOn day 2, the cells were switched to medium A containing 5%
fraction. We interpret the results of Figures 5 and 6 tolipoprotein-deficient serum, 50 mM compactin (an inhibitor of cho-
indicate that sterols inhibit export of SCAP from the ERlesterol synthesis), 50 mM sodium mevalonate, 0.5% ethanol, and
1% HPCD and incubated at 378C for 1 hr. The cells were then by specifically blocking its incorporation into transport
incubated for the indicated time with medium A containing 5% lipo- vesicles.
protein-deficient serum, 50 mM compactin, 50 mM sodium mevalo- Figure 7 shows an experiment in which the sterol
nate, and 0.5% ethanol in the absence or presence of sterols (1 mg/ specificity for the inhibition of SCAP budding was exam-
ml 25-HC plus 10 mg/ml cholesterol). Additions of sterols were made ined. CHO-K1 cells were incubated with increasing con-
in a staggered fashion such that all samples were harvested at the
centrations of different sterols, after which microsomessame time. Microsomes were prepared and analyzed in the in vitro
were prepared and used in the standard in vitro vesicle-vesicle-formation assay for 15 min at 378C as described in Figure
formation assay. Incubation of cells with 25-hydroxy-4. Vesicle and membrane fractions were analyzed by SDS-PAGE
cholesterol at a concentration as low as 0.1 mg/ml ledand immunoblotted with IgG-R139 (anti-SCAP). (B) On day 0, CHO/
VSVG-T7 cells were set up in medium A containing 5% FCS and to a marked decrease in SCAP budding (Figure 7A, lane
cultured at 408C. On day 2, cells were refed with medium A con- 6; and Figure 7B, lane 3). 20-Hydroxycholesterol was
taining 5% lipoprotein-deficient serum, 50 mM compactin, 50 mM the second most potent sterol with complete inhibition
sodium mevalonate, 0.5% ethanol, and 1% HPCD, and incubated of budding at 1 mg/ml, followed by 7-ketocholesterol
at 408C for 1 hr. Cells were then washed twice with PBS and refed with complete inhibition at 10 mg/ml. Cholesterol and
with medium A containing 5% lipoprotein-deficient serum, 50 mM
progesterone had no significant effect at concentrationscompactin, 50 mM sodium mevalonate, and 0.5% ethanol in the
up to 10 mg/ml. The lack of effect of cholesterol is at-absence or presence of the indicated concentration of 25-HC, and
tributable to inefficient cellular uptake from ethanolincubated at 408C for 3 hr (lanes 1±12). A replicate set of cells
solutions (Krieger et al., 1978). This order of potencywere cultured at 408C in medium A containing 5% FCS, but then
transferred to 328C (without change of medium) for the last 4 hr precisely matches that previously observed for sterol-
(lane 13). All cells were harvested at the same time, and microsome mediated suppression of SREBP-1 cleavage in HeLa
fractions were incubated for 15 min in the standard in vitro vesicle- cells (Wang et al., 1994).
formation assay as described in Figure 4, except that the cells were
not frozen prior to preparation of microsomes and the temperature
Budding of SREBP Dependent on SCAPof the budding reaction was 328C rather than 378C. Vesicle (lanes
If the in vitro membrane budding assay reflects the phys-1±6) and membrane (lanes 7±13) fractions were subjected to SDS-
PAGE and immunoblotted with IgG-R139 (anti-SCAP), anti-T7·Tag iologic transport that occurs in vivo, then SREBPs
(VSVG-T7), anti-p58, and anti-ribophorin I. VGO and VER denote the should be incorporated into budding vesicles only when
Golgi-modified and ER forms of VSVG-T7, respectively. SCAP is present. To test this prediction, we transfected
SCAP-deficient SRD-13A cells with plasmids encoding
HSV-tagged SREBP-1a with or without SCAP. Cells were
depleted of sterols for 2 hr, after which microsomes werewidely-studied of these proteins is vesicular stomatitis
virus glycoprotein (VSVG), the envelope glycoprotein prepared and subjected to an in vitro vesicle-formation
assay. In cells that lacked SCAP, the vesicles containedfrom the temperature-sensitive strain tsO45. At 408C,
VSVG/tsO45 misfolds and accumulates in the ER. Upon a small amount of SREBP-1a (lane 2). Coexpression of
Cell
320
Figure 8. In Vitro Budding of SREBP Requires SCAP
On day 0, SRD-13A cells were set up at 6 3 105 cells per 10 cm
dish as described in Experimental Procedures. On day 2, plasmid
Figure 7. Sterol Specificity of Inhibition of SCAP Budding in Ham- encoding HSV-tagged SREBP-1a (3 mg/dish, lanes 2 and 7; 1 mg/
ster Cell Membranes dish, lanes 3±5 and 8±10) (Hua et al., 1996b) was cotransfected with
pCMV-SCAP (1 mg/dish; lanes 3±5 and 8±10) (Sakai et al., 1997) orOn day 0, CHO-K1 cells were set up as described in Figure 4. On
pVSVG-T7 (0.5 mg/dish; lanes 2±5 and 7±10) as indicated. The plas-day 2, cells were switched to medium A containing 5% lipoprotein-
mid pVAI, which increases protein expression from cotransfecteddeficient serum, 50 mM compactin, 50 mM sodium mevalonate, 0.5%
cDNAs (Akusjarvi et al., 1987), was used to normalize the amountethanol, and 1% HPCD and incubated at 378C for 1 hr. The cells were
of HSV-SREBP-1a in the absence of the stabilizing SCAP protein (1refed with medium A containing 5% lipoprotein-deficient serum, 50
mg/dish, lanes 1±2 and 6±7). Total amount of DNA was adjusted tomM compactin, 50 mM sodium mevalonate, 0.5% ethanol, and the
5.5 mg/dish by addition of pTK and pcDNA3 empty vectors. Trans-indicated concentrations of cholesterol (Chol.), 25-HC, 20-hydroxy-
fection was performed for 20 hr in medium A containing 5% FCScholesterol (20-HC), 7-ketocholesterol (7-Keto), or progesterone
as described (DeBose-Boyd et al., 1999). On day 3, cells were de-(Prog.). Cells were then incubated at 378C for 3 hr and harvested.
pleted of sterols as in Figure 4. Microsomes were prepared and usedMicrosomes were prepared and used in an in vitro vesicle-formation
in the in vitro vesicle-formation assay as described in Experimentalassay as described in Figure 4. The resulting vesicle and membrane
Procedures with the following modifications: Buffers E and F con-fractions were subjected to SDS-PAGE and immunoblotted with
tained 1.5 and 0.5 mM Mg(OAc)2, respectively, and the reactionsIgG-R139 (anti-SCAP).
were performed at 288C for 15 min in the standard buffer containing
1.5 mM rather than 2.5 mM Mg(OAc)2. Vesicles (lanes 1±5) and mem-
brane (lanes 6±10) fractions were subjected to SDS-PAGE and im-SCAP increased incorporation of SREBP-1a into vesi-
munoblotted with anti-HSV·Tag (SREBP-1a), IgG-R139 (anti-SCAP),
cles by 9-fold (lane 3). SCAP-dependent budding of anti-T7·Tag (VSVG-T7), and anti-ribophorin I. Asterisk (*) denotes a
SREBP-1a required cytosol and temperature (lanes 4 cytosolic protein that crossreacts with anti-HSV·Tag antibody.
and 5). Coexpression of SCAP did not increase the bud-
ding of co-transfected VSVG-T7 (compare lanes 2 and 3).
formed in the cell periphery and migrated to the Golgi
Discussion region. The colocalization of GFP-SCAP fluorescence
and a-mannosidase II immunofluorescence indicates
that GFP-SCAP reached the region of the Golgi complex.The current experiments, conducted in vivo and in vitro,
provide strong support for the conclusion that sterols However, the resolution of the confocal microscope is
insufficient to determine whether GFP-SCAP actuallyblock the proteolytic processing of SREBPs by inhibiting
the incorporation of SCAP into ER-derived vesicles that entered the Golgi stacks or whether it remained in Golgi-
associated intermediate compartments.carry the SCAP/SREBP complex to the Site-1 protease.
The experiments also provide a new system that should The experiments with GFP-SCAP must be interpreted
in light of the fact that the amount of GFP-SCAP in thepermit a dissection of the biochemical mechanism for
this regulation. In the in vivo experiments, GFP-SCAP permanently transfected cells was at least 10-fold higher
than the amount of SCAP in wild-type CHO cells aswas observed to exit the ER within 30 min after cellular
sterols were depleted by treatment with HPCD (Figure estimated by immunoblotting (data not shown). Despite
the overabundance of GFP-SCAP in the transfected3). In the in vitro experiments, the budding of SCAP into
ER-derived vesicles was increased when the mem- cells, SREBP processing was regulated normally by ste-
rols (Figure 1), indicating that the overexpressed GFP-branes were isolated after 15±30 min of cellular sterol
depletion (Figure 5). This correlation helps to validate SCAP was interacting with SREBP and exiting the ER
in a normal sterol-controlled manner. The proportion ofthe in vitro assay as a true measure of the physiologically
regulated budding process. The data also indicate that GFP-SCAP that exited the ER and the proportion that
recycled back to the ER before or after reaching thesterol depletion alters the properties of SCAP in the ER
membrane in a fashion that persists when the mem- Golgi complex cannot be determined from these stud-
ies. Previous experiments suggest that SCAP recyclesbranes form vesicles in vitro.
After leaving the ER in sterol-depleted cells, the GFP- to the ER from the S1P-containing Golgi compartment
(Nohturfft et al., 1999).SCAP fusion protein followed a route that was similar
to the route previously described for the movement of After cells were depleted of sterols, there was a close
correspondence between the time required to visualizeGFP-tagged VSVG protein (Presley et al., 1997). GFP-
SCAP was observed to concentrate in vesicles that GFP-SCAP movement to the Golgi in vivo (Figure 3) and
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the time required to detect increased SCAP budding suppressed selectively under conditions in which the
from membranes in vitro (Figure 5A). Budding was dimin- general process of vesicle budding is unaffected (Fig-
ished when membranes were prepared either from cells ure 6B).
that were treated with increasing amounts of exoge-
nously added sterols (Figures 6 and 7) or from cells that Experimental Procedures
overproduced endogenous cholesterol as a result of
an SREBP truncation (unpublished observations). The Materials
We obtained rabbit muscle creatine kinase and the sodium salts ofsterol specificity for suppression of SCAP budding in
ATP, GTP, and creatine phosphate from Boehringer; cholesterolvitro (Figure 7) matched the known sterol specificity
from Alltech; 25-HC from Steraloids; N-acetyl-leucinal-leucinal-nor-for the regulation of SREBP processing and cholesterol
leucinal (ALLN) and hexyl-b-D-glucopyranoside from Calbiochem;synthesis in vivo (Wang et al., 1994). Moreover, in vitro
HPCD from Cyclodextrin Technologies Development (Gainesville,budding was not suppressed completely by sterols in
FL); monoclonal anti-KDEL antibody (IgG fraction) from StressGencells that expressed mutants of SCAP that are known
(Victoria, Canada); monoclonal anti-T7·Tag antibody and anti-
to be sterol resistant (unpublished observations). All of HSV·Tag antibody from Novagen; and horseradish peroxidase-con-
these observations support the assertion that the in vitro jugated, affinity-purified donkey anti-mouse and anti-rabbit IgG from
assay measured the physiologically relevant budding Jackson ImmunoResearch. Polyclonal antibody IgG-R139 raised
process. against hamster SCAP (amino acids 54±277 and 540±707) (Sakai et
al., 1997), monoclonal antibody IgG-2A4 against human SREBP-1aIn order to observe SCAP budding in vitro, it is neces-
(amino acids 301±407) (Sato et al., 1994), and monoclonal antibodysary first to deplete the cells of sterols. Under these
IgG-7D4 against hamster SREBP-2 (amino acids 32±250) (Yang etconditions, nearly all of the SREBP precursor disappears
al., 1995) have been described in the indicated references. Otherbecause it is processed to the mature form. Therefore,
polyclonal antibodies used in this study were generous gifts frommost of the SCAP in the budding vesicles is not likely to
the following laboratories: K. Moremen, University of Georgia, Ath-be associated with SREBPs. To demonstrate the SCAP
ens, GA (anti-rat Golgi a-mannosidase II); J. Saraste, University of
dependence of SREBP-budding in vitro, we used mem- Bergen, Bergen, Norway (anti-rat p58); T. Rapoport, Harvard Medical
branes prepared from SRD-13A cells that lack endoge- School, Boston, MA and D. I. Meyer, University of California, Los
nous SCAP. Inasmuch as these cells have low levels of Angeles, CA (anti-rat ribophorin I). Solutions of compactin and so-
SREBP precursors (Rawson et al., 1999), it was neces- dium mevalonate were prepared as previously described (Brown et
al., 1978; Kita et al., 1980). Newborn calf lipoprotein-deficient serumsary to perform a transfection with a cDNA encoding
(d . 1.25 g/ml) was prepared by ultracentrifugation (Goldstein etSREBP-1a (Figure 8). Under these conditions, cotrans-
al., 1983).fection of a cDNA encoding SCAP led to a major increase
in SREBP budding in vitro. This SCAP dependence in
vitro mirrors the SCAP dependence of SREBP cleavage Plasmid Constructions
pGFP-SCAP encodes an Enhanced Green Fluorescent Protein/in vivo (Rawson et al., 1999), providing further evidence
SCAP fusion protein (1539 amino acids), consisting of amino acidsfor the physiologic relevance of the in vitro budding
1±239 of Enhanced Green Fluorescent Protein (Cormack et al., 1996),assay.
25 amino acids encoded by a polylinker sequence, and amino acidsThe sterol-regulated exit of SCAP from the ER appears
2±1276 of hamster SCAP (Hua et al., 1996a). Expression is drivento represent the first observed example of an ER exit
by the CMV promoter/enhancer.
process that is under metabolic control. Metabolic con- pVSVG-T7 encodes amino acids 1±512 of VSVG protein from the
trol differs from the quality-control process by which ts045 mutant strain of vesicular stomatitis virus (Gallione and Rose,
proteins are retained in the ER until they have undergone 1985), followed by four novel amino acids (RTAA, codons generated
proper folding or posttranslational modification (Ell- by blunt-end ligation of filled-in BsiWI and NotI restriction sites),
gaard et al., 1999). In the case of SCAP, ER retention is followed by two copies of the T7 tag (corresponding to the amino-
terminal 11 amino acids of the T7 gene 10 protein). Codons 1±512a central event in a physiologically regulated process.
of VSVG/tsO45 were derived from pVSVG-GFP (Presley et al., 1997).The data from the in vitro assay establish that sterol
Expression is driven by the CMV promoter/enhancer.depletion alters SCAP in the ER membrane as opposed
to altering a cytosolic factor. In the budding assays, we
Cell Cultureused a constant preparation of cytosol obtained from
Chinese hamster ovary (CHO-K1) cells were grown in monolayer atlivers of rats that were not deprived of cholesterol. The
378C in an atmosphere of 8%±9% CO2 in medium A (a 1:1 mixturedifference in the budding activity of ER membranes from
of Ham's F-12 medium and Dulbecco's modified Eagle mediumsterol-depleted and sterol-overloaded cells must have
containing 100 units/ml penicillin and 100 mg/ml streptomycin sul-been caused by an alteration in SCAP or in some other
fate) supplemented with 5% (v/v) FCS. SRD-13A cells, a mutantcomponent of the membranes. subclone of CHO-7 cells (Rawson et al., 1999), were maintained in
The mechanism by which SCAP is retained in the ER medium A supplemented with 5% FCS 5 mg/ml cholesterol, 1 mM
of sterol-replete cells is unknown. One possibility is that sodium mevalonate, and 20 mM sodium oleate.
SCAP binds directly to sterols, thereby inducing a con- CHO/pGFP-SCAP cells were generated by transfection of SCAP-
formational change that abrogates its interaction with deficient SRD-13A cells with pGFP-SCAP, followed by selection in
medium A supplemented with 5% newborn calf lipoprotein-deficientthe cytosolic COPII budding machinery, which controls
serum. pGFP-SCAP rescued the cholesterol auxotrophy of SRD-incorporation of cargo into ER vesicles (Springer et al.,
13A cells. Fluorescent colonies were cloned by limiting dilution. One1999). Another model, perhaps more likely, postulates
clone that exhibited strong fluorescence, designated CHO/pGFP-that SCAP binds to a resident protein that holds it in
SCAP, was expanded and used for experiments.the ER in the presence of sterols. When sterols are
CHO/VSVG-T7 cells were generated by transfection of CHO-K1depleted, SCAP dissociates from this protein, and it is cells with pVSVG-T7, followed by selection in medium A supple-
thereby free to enter budding vesicles. Whether these mented with 5% FCS and 0.7 mg/ml G418. Surviving colonies were
vesicles are the same as the ones that carry VSVG pro- isolated with cloning cylinders, expanded, and screened for expres-
tein and other cargo, or whether SCAP enters a distinct sion of VSVG-T7 by immunoblotting. One positive clone, designated
population of vesicles, is currently unknown. It is clear, CHO/VSVG-T7 was cloned by dilution plating, expanded, and used
for experiments.however, that SCAP entry into budding vesicles can be
Cell
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Buffers below). To determine the protein concentration, aliquots of the mi-
crosomal suspensions (5 ml) were added to 5 ml of a solution of 20%The following buffers were used: PBS refers to phosphate-buffered
saline, pH 7.4 (Cat. No. 21±031-CV, Mediatech, Herndon, VA). Buffer (w/v) of hexyl-b-D-glucopyranoside (Fanger, 1987) and assayed with
Coomassie Plus Protein Assay Reagent (Pierce) according to theB contains PBS plus protease inhibitors (10 mg/ml leupeptin, 5 mg/
ml pepstatin A, 2 mg/ml aprotinin, 25 mg/ml ALLN). Buffer C contains manufacturer's instructions using bovine serum albumin as a
standard.10 mM Tris-HCl at pH 7.6, 100 mM NaCl, 1% (w/v) SDS plus protease
inhibitors. Buffer D contains 150 mM Tris-HCl at pH 6.8, 15% SDS,
25% (v/v) glycerol, 0.02% (w/v) bromophenol blue, and 12.5% (v/v) In Vitro Vesicle-Formation Assay
2-mercaptoethanol. Buffer E contains 50 mM HEPES-KOH at pH The protocol used in this study was adapted from procedures de-
7.2, 250 mM sorbitol, 70 mM KOAc, 5 mM potassium EGTA, 2.5 mM scribed by the laboratories of Schekman (Rexach and Schekman,
Mg(OAc)2 plus protease inhibitors. Buffer F contains 10 mM HEPES- 1991) and Balch (Rowe et al., 1996). Each reaction contained, in a
KOH at pH 7.2, 250 mM sorbitol, 10 mM KOAc, 1.5 mM Mg(OAc)2 final volume of 80 ml, 50 mM HEPES-KOH at pH 7.2, 250 mM sorbitol,
plus protease inhibitors. 70 mM KOAc, 5 mM potassium EGTA, 2.5 mM Mg(OAc)2, 1.5 mM
ATP, 0.5 mM GTP, 10 mM creatine phosphate, 4 units/ml of creatine
kinase, protease inhibitors (described above under Buffers), 30±80Time-Lapse Imaging
mg protein of CHO microsomes, and 600 mg of rat liver cytosol.On day 0, cells were set up in glass-bottomed 35 mm dishes (Mat
Incubations were carried out in siliconized 1.5 ml microcentrifugeTek Co., Ashland, MA) at a density of 3 3 104 cells/dish in medium
tubes for 15 min at 378C (unless otherwise stated). Reactions wereA supplemented with 5% FCS. On day 2, cells were washed with
terminated by transfer of tubes to ice, followed by centrifugation atPBS and refed 1 ml of medium A supplemented with 5% newborn
1.6 3 104 g for 3 min at 48C to obtain a medium-speed pellet (P16)calf lipoprotein-deficient serum and 0.2% ethanol. During the experi-
and a medium-speed supernatant (S16). Aliquots (60 ml) of each S16ment, cells were maintained at 378C in 5% CO2 in an environmental
fraction were collected from the top of each sample and centrifugedchamber that encased the microscope stage. To start the experi-
again at 5.5 3 104 rpm at 48C in a Beckman TLA100 rotor to obtainment, 1 ml of medium A supplemented with 5% newborn calf lipo-
a high speed pellet (P100). P16 and P100 fractions were each resus-protein-deficient serum and 2% (w/v) HPCD was added to the dish.
pended in 60 ml of Buffer C, supplemented with 15 ml of Buffer D,The first image (t 5 0 min) was recorded 4 min after addition of
and heated at 958C for 5 min. Aliquots of the P16 (20 ml) and P100HPCD. GFP-SCAP was visualized with an inverted Leica TCS SP
fractions (75 ml) were subjected to 7% SDS-PAGE, transferred toconfocal microscope using a 488 nm laser and a Leica 633/NA 1.3
nitrocellulose, and analyzed by immunoblotting. The P16 and P100PL APO oil immersion objective with a pinhole set to 1.5 times the
fractions are referred to as membranes and vesicles, respectively.Airy disk diameter. Digital images were captured every 2.5 min for
2.5 hr with no significant loss of signal. Images were edited using
Adobe Photoshop 4.0, and the Quicktime movie was generated Immunoblot Analysis
using Adobe Premier 5.1. Gels were calibrated with molecular weight markers (Amersham or
BioRad), and antibodies were used at the following concentrations:
anti-SCAP IgG-R139, 5 mg/ml; anti-p58 serum, 1 ml/ml; anti-KDEL
Preparation of Rat Liver Cytosol
antibody (IgG fraction), 2 mg/ml; anti-ribophorin I serum, 0.2 ml/ml;
Male Sprague-Dawley rats (350±400 g) were housed in colony cages,
anti-SREBP-1 IgG-2A4, 5 mg/ml; anti-SREBP-2 IgG-7D4, 5 mg/ml;
maintained on a 12 hr light/12 hr dark cycle, and fed a Harlan Teklad
anti-T7, 1 mg/ml; anti-HSV, 0.5 mg/ml; anti-rabbit IgG, 0.33 ml/ml;
4% Mouse/Rat Diet 7001. At 3 hr into the dark cycle, the rats were
anti-mouse IgG, 0.2 ml/ml. Bound antibodies were visualized by
anesthetized by halothane inhalation followed by an intraperitoneal
chemiluminescence using the Supersignal Substrate System
injection of nembutal, after which their livers were perfused with
(Pierce) and exposed to Kodak X-Omat Blue XB-1 film (NEN) at
0.9% (w/v) NaCl through the portal vein at room temperature. The
room temperature for 1±120 s.
livers were excised and disrupted in 2 ml/g of ice-cold Buffer E
supplemented with 1 mM dithiothreitol in a Polytron homogenizer
Acknowledgmentsfollowed by 10 strokes in a 50 ml Dounce homogenizer fitted with
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